Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2007;60:1048-1050; doi:10.1136/jcp.2006.043547
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

ORIGINAL ARTICLE

Implications of method specific creatinine adjustments on General Medical Services chronic kidney disease classification

Timothy M Reynolds1, Patrick J Twomey2

1 Department of Chemical Pathology, Queen’s Hospital, Burton-on-Trent, UK
2 Department of Clinical Biochemistry, The Ipswich Hospital, Ipswich, UK

Correspondence to:
Correspondence to:
Professor T M Reynolds
Department of Chemical Pathology, Queen’s Hospital, Burton-on-Trent DE13 0RB, UK; tim.reynolds{at}burtonh-tr.wmids.nhs.uk

Aims: To evaluate the impact of different equations for calculation of estimated glomerular filtration rate (eGFR) on general practitioner (GP) workload.

Methods: Retrospective evaluation of routine workload data from a district general hospital chemical pathology laboratory serving a GP patient population of approximately 250 000. The most recent serum creatinine result from 80 583 patients was identified and used for the evaluation. eGFR was calculated using one of three different variants of the four-parameter Modification of Diet in Renal Disease (MDRD) equation.

Results: The original MDRD equation (eGFR186) and the modified equation with assay-specific data (eGFR175corrected) both identified similar numbers of patients with stage 4 and stage 5 chronic kidney disease (ChKD), but the modified equation without assay specific data (eGFR175) resulted in a significant increase in stage 4 ChKD. For stage 3 ChKD the eGFR175 identified 28.69% of the population, the eGFR186 identified 21.35% of the population and the eGFR175corrected identified 13.6% of the population.

Conclusions: Depending on the choice of equation there can be very large changes in the proportions of patients identified with the different stages of ChKD. Given that according to the General Medical Services Quality Framework, all patients with ChKD stages 3–5 should be included on a practice renal registry, and receive relevant drug therapy, this could have significant impacts on practice workload and drug budgets. It is essential that practices work with their local laboratories.

Abbreviations: ChKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; GFR, glomerular filtration rate; GP, general practitioner; GMS, General Medical Services; IDMS, isotope dilution mass spectroscopy; MDRD, Modification of Diet in Renal Disease; UKNEQAS, United Kingdom National External Quality Assessment Service

Keywords: GMS; chronic kidney disease; eGFR; screening


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Kremmyda, A, Neithercut, W D (2009). A review of eGFR reporting after 6 months in practice. J. Clin. Pathol. 62: 345-349 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
BMJ Learning
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs